Multivariable association of an episode of AKI and change (fold increase) in level of urine protein-to-creatinine ratio overall and analyses that exclude receipt of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker or systolic BP level
| Comparisons | Full Model (Shown in Supplemental Table 2) | Model Excluding Receipt of ACE-I/ARB | Model Excluding Systolic BP Level | |||
|---|---|---|---|---|---|---|
| Relative Risk (95% CI) | P Value | Relative Risk (95% CI) | P Value | Relative Risk (95% CI) | P Value | |
| AKI between study visits (versus no AKI) | 1.09 (1.02 to 1.16) | 0.01 | 1.09 (1.02 to 1.17) | 0.01 | 1.07 (1.00 to 1.14) | 0.04 |
ACE-I, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; 95% CI, 95% confidence interval.